高雪氏症:全球臨床實驗檢討

本報告提供全球各國高雪氏症臨床實驗相關調查，地區·進展·階段·各募集情況的實驗量，代表性贊助商，正在開發的治療藥物的資訊，各企業機關的進行狀況等資訊彙整，為您概述為以下內容。

目錄

簡介

• 高雪氏症
• 本報告的內容架構

不同地區的臨床實驗趨勢

• 各國臨床實驗趨勢
  • 亞太地區臨床實驗數量:前幾名國家
  • 歐洲臨床實驗數量:前5個國家
  • 北美臨床實驗數量:前幾名國家
  • 中東/非洲臨床實驗數量:前5個國家
  • 中南美臨床實驗數量:前5個國家

金磚四國的臨床實驗趨勢

G7各國的臨床實驗趨勢

E7各國的臨床實驗趨勢

各階段臨床實驗趨勢

• 進行中的臨床實驗:各階段

各進展狀況臨床實驗趨勢

高雪氏症的尚未完成的臨床實驗

一定期間內採用的實驗人數數

著名的贊助商

• 高雪氏症參與臨床實驗的主要企業

著名的治療藥物比較

臨床實驗簡介

• 主要企業臨床實驗概況
  • Genzyme Corporation
  • Shire Plc
  • Protalix BioTherapeutics, Inc.
  • Amicus Therapeutics, Inc.
  • Shire Human Genetic Therapies, Inc.
  • Protalix Ltd.
  • Actelion Pharmaceuticals Ltd
  • University Research Foundation for Lysosomal Storage Diseases, Inc.
  • O & O Alpan, LL
  • ExSAR Corporation
  • ISU ABXIS Co.,Ltd.
  • Actelion Ltd
  • Abbott Laboratories
• 主要的大學·研究機關·醫院臨床實驗概況
  • University of Minnesota
  • Assistance Publique - Hopitaux de Paris
  • Rabin Medical Center
  • University of Rostock
  • Istituto Giannina Gaslini
  • Academic Medical Centre
  • New York Medical College
  • Masonic Cancer Center
  • The Children's Hospital of Philadelphia
  • Shaare Zedek Medical Center
  • Nantes University Hospital

5個有代表性的臨床實驗簡介

附錄

圖表一覽

Abstract

Gaucher's Disease Global Clinical Trials Review, H2, 2012

Summary

GlobalData's clinical trial report, "Gaucher's Disease Global Clinical Trials Review, H2, 2012" provides data on the Gaucher's Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher's Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gaucher's Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Gaucher's Disease Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Gaucher's Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

TOC

Table of Contents

Table of Contents 2

• List of Tables 4
• List of Figures 5
• Introduction 6
• Gaucher's Disease 6
• Report Guidance 6
• Clinical Trials by Region 7
• Clinical Trials by Country 8
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
• Top Five Countries Contributing to Clinical Trials in Europe 11
• Top Countries Contributing to Clinical Trials in North America 12
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
• Top Five Countries Contributing to Clinical Trials in Central and South America 14
• Clinical Trials by BRIC Nations 15
• Clinical Trials by G7 Nations 16
• Clinical Trials in G7 Nations by Trial Status 17
• Clinical Trials by E7 Nations 18
• Clinical Trials in E7 Nations by Trial Status 19
• Clinical Trials by Phase 20
• In Progress Trials by Phase 21
• Clinical Trials by Trial Status 22
• Unaccomplished Trials of Gaucher's Disease 23
• Subjects Recruited Over a Period of Time 24
• Prominent Sponsors 25
• Top Companies Participating in Gaucher's Disease Therapeutics Clinical Trials 27
• Prominent Drug Comparison 29
• Clinical Trial Profiles 30
• Clinical Trial Overview of Top Companies 30
• Genzyme Corporation 30
• Clinical Trial Overview of Genzyme Corporation 30
• Shire Plc 31
• Clinical Trial Overview of Shire Plc 31
• Protalix BioTherapeutics, Inc. 32
• Clinical Trial Overview of Protalix BioTherapeutics, Inc. 32
• Amicus Therapeutics, Inc. 33
• Clinical Trial Overview of Amicus Therapeutics, Inc. 33
• Shire Human Genetic Therapies, Inc. 34
• Clinical Trial Overview of Shire Human Genetic Therapies, Inc. 34
• Protalix Ltd. 35
• Clinical Trial Overview of Protalix Ltd. 35
• Actelion Pharmaceuticals Ltd 36
• Clinical Trial Overview of Actelion Pharmaceuticals Ltd 36
• University Research Foundation for Lysosomal Storage Diseases, Inc. 37
• Clinical Trial Overview of University Research Foundation for Lysosomal Storage Diseases, Inc. 37
• O & O Alpan, LLC 38
• Clinical Trial Overview of O & O Alpan, LLC 38
• ExSAR Corporation 39
• Clinical Trial Overview of ExSAR Corporation 39
• ISU ABXIS Co.,Ltd. 40
• Clinical Trial Overview of ISU ABXIS Co.,Ltd. 40
• Actelion Ltd 41
• Clinical Trial Overview of Actelion Ltd 41
• Abbott Laboratories 42
• Clinical Trial Overview of Abbott Laboratories 42
• Clinical Trial Overview of Top Universities / Institutes / Hospitals 43
• University of Minnesota 43
• Clinical Trial Overview of University of Minnesota 43
• Assistance Publique - Hopitaux de Paris 44
• Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 44
• Rabin Medical Center 45
• Clinical Trial Overview of Rabin Medical Center 45
• University of Rostock 46
• Clinical Trial Overview of University of Rostock 46
• Istituto Giannina Gaslini 47
• Clinical Trial Overview of Istituto Giannina Gaslini 47
• Academic Medical Centre 48
• Clinical Trial Overview of Academic Medical Centre 48
• New York Medical College 49
• Clinical Trial Overview of New York Medical College 49
• Masonic Cancer Center 50
• Clinical Trial Overview of Masonic Cancer Center 50
• The Children's Hospital of Philadelphia 51
• Clinical Trial Overview of The Children's Hospital of Philadelphia 51
• Shaare Zedek Medical Center 52
• Clinical Trial Overview of Shaare Zedek Medical Center 52
• Nantes University Hospital 53
• Clinical Trial Overview of Nantes University Hospital 53
• Five Key Clinical Profiles 54

Appendix 75

• Abbreviations 75
• Definitions 75
• Research Methodology 76
• Secondary Research 76
• About GlobalData 77
• Contact Us 77
• Disclaimer 77
• Source 78

List of Tables

List of Figures

• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
• Gaucher's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10
• Gaucher's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
• Gaucher's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
• Gaucher's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 13
• Gaucher's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 14
• Gaucher's Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15
• Gaucher's Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
• Gaucher's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
• Gaucher's Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 18
• Gaucher's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
• Gaucher's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
• Gaucher's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
• Gaucher's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
• Gaucher's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
• GlobalData Methodology 76

List of Figures

List of Figures

• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
• Gaucher's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10
• Gaucher's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
• Gaucher's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
• Gaucher's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 13
• Gaucher's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 14
• Gaucher's Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15
• Gaucher's Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
• Gaucher's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
• Gaucher's Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 18
• Gaucher's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
• Gaucher's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
• Gaucher's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
• Gaucher's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
• Gaucher's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
• Gaucher's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
• GlobalData Methodology 76